Daniel P. van Plew - 15 Nov 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP & General Mgr, Industrial
Signature
/s/** Daniel P. Van Plew
Issuer symbol
REGN
Transactions as of
15 Nov 2021
Net transactions value
-$9,380,857
Form type
4
Filing time
17 Nov 2021, 15:02:53 UTC
Previous filing
10 Aug 2021
Next filing
10 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $6,760,750 +25,000 +93% $270.43 51,931 15 Nov 2021 Direct
transaction REGN Common Stock Tax liability $11,689,413 -18,222 -35% $641.50 33,709 15 Nov 2021 Direct
transaction REGN Common Stock Sale $344,362 -528 -1.6% $652.20 33,181 16 Nov 2021 Direct F1
transaction REGN Common Stock Sale $548,864 -840 -2.5% $653.41 32,341 16 Nov 2021 Direct F2
transaction REGN Common Stock Sale $824,456 -1,260 -3.9% $654.33 31,081 16 Nov 2021 Direct F3
transaction REGN Common Stock Sale $229,260 -350 -1.1% $655.03 30,731 16 Nov 2021 Direct F4
transaction REGN Common Stock Sale $131,436 -200 -0.65% $657.18 30,531 16 Nov 2021 Direct F5
transaction REGN Common Stock Sale $458,974 -697 -2.3% $658.50 29,834 16 Nov 2021 Direct F6
transaction REGN Common Stock Sale $1,584,586 -2,403 -8.1% $659.42 27,431 16 Nov 2021 Direct F7
transaction REGN Common Stock Sale $330,255 -500 -1.8% $660.51 26,931 16 Nov 2021 Direct F8
holding REGN Common Stock 1,048 15 Nov 2021 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -25,000 -100% $0.000000* 0 15 Nov 2021 Common Stock 25,000 $270.43 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents volume-weighted average price of sales of 528 shares of Company stock on November 16, 2021 at prices ranging from $652.01 to $652.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F2 Represents volume-weighted average price of sales of 840 shares of Company stock on November 16, 2021 at prices ranging from $653.03 to $653.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F3 Represents volume-weighted average price of sales of 1,260 shares of Company stock on November 16, 2021 at prices ranging from $654.03 to $654.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F4 Represents volume-weighted average price of sales of 350 shares of Company stock on November 16, 2021 at prices ranging from $655.01 to $655.07. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F5 Represents volume-weighted average price of sales of 200 shares of Company stock on November 16, 2021 at prices ranging from $657.09 to $657.34. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F6 Represents volume-weighted average price of sales of 697 shares of Company stock on November 16, 2021 at prices ranging from $658.03 to $658.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F7 Represents volume-weighted average price of sales of 2,403 shares of Company stock on November 16, 2021 at prices ranging from $659.01 to $659.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F8 Represents volume-weighted average price of sales of 500 shares of Company stock on November 16, 2021 at prices ranging from $660.33 to $660.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F9 The stock option award vests in four equal annual installments, commencing one year after the date of grant.